I initiate coverage on Forte Biosciences stock at a 'Hold' rating due to both pipeline risk and upcoming clinical catalysts.

Not every Diablo story needs a bug, a meltdown, or a demon made of unpaid QA overtime. Sometimes the news is smaller than ...

Iranian Delegation Arrives at Peace Talks, With Vance en Route Israel and Lebanon will hold talks in Washington next week. A senior Iranian official says ‘blocked assets’ must be released before peace ...